Disclosure Of Interests In Other Entities [Text Block]

BerGenBio - Filing #5877180

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Disclosure of interests in other entities [text block]		—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]		—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	—	154,543,000 NOK	—	—	—	—	—	173,904,000 NOK	—	—	—
Non-current assets	—	—	—	1,254,000 NOK	—	—	—	—	—	431,000 NOK	—	—	—
Current liabilities	—	—	—	32,277,000 NOK	—	—	—	—	—	46,859,000 NOK	—	—	—
Non-current liabilities	—	—	—	818,000 NOK	—	—	—	—	—	0 NOK	—	—	—
Revenue	848,000 NOK	—	—	—	—	—	—	—	354,000 NOK	—	—	—	—
Profit (loss)	139,282,000 NOK	—	—	—	—	139,282,000 NOK	—	—	190,401,000 NOK	—	—	190,401,000 NOK	—
Comprehensive income	140,531,000 NOK	0 NOK	0 NOK	—	0 NOK	140,531,000 NOK	0 NOK	0 NOK	189,234,000 NOK	—	0 NOK	189,234,000 NOK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	140,155,000 NOK	—	—	—	—	—	156,421,000 NOK	—	—	150,803,000 NOK
Tax expense (income)	0 NOK	—	—	—	—	—	—	—	0 NOK	—	—	—	—